Stocks
Relmada Therapeutics, Inc.RLMD
NASDAQHealthcareBiotechnology$5.91-3.90%
A clinical-stage biotechnology company focused on developing therapies for central nervous system disorders, particularly major depressive disorder and other neuropsychiatric conditions. Its lead program, REL-1017 (esmethadone), has been studied as a rapid-acting oral treatment for depression. Inves...
Market Cap: $433.4M52W Range: $0.24 – $7.51
Congressional Interest in Relmada Therapeutics, Inc. (RLMD)
1 member of Congress has disclosed 2 trades in Relmada Therapeutics, Inc. (RLMD), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading RLMD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | buy | $1K – $15K |